aluates Reports

$ 0.0

Automative

Global Prostate Cancer Diagnostics and Treatment Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-20I13710

Global Prostate Cancer Diagnostics and Treatment Market Research Report 2023

BUY CHAPTERS

Global Prostate Cancer Diagnostics and Treatment Market Research Report 2025

Code: QYRE-Auto-20I13710

Report

January 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Tolmar

Astellas Pharma

Astrazeneca plc

Ferring Pharmaceuticals

Johnson & Johnson

Abbott

Sanofi

Ipsen S A

Novartis

Bayer

Prostate Cancer Diagnostics and Treatment Market Size

The global market for Prostate Cancer Diagnostics and Treatment was valued at US$ 14410 million in the year 2024 and is projected to reach a revised size of US$ 18900 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Prostate Cancer Diagnostics and Treatment Market

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Diagnostics and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Diagnostics and Treatment.

The Prostate Cancer Diagnostics and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prostate Cancer Diagnostics and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Diagnostics and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate Cancer Diagnostics and Treatment Market Report

Report Metric	Details
Report Name	Prostate Cancer Diagnostics and Treatment Market
Accounted market size in year	US$ 14410 million
Forecasted market size in 2031	US$ 18900 million
CAGR	4.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Biological Therapy Chemotherapy
Segment by Application	Hospital Research Institution Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Tolmar, Astellas Pharma, AstraZeneca, Ferring Pharmaceuticals, Johnson & Johnson, Abbott, Sanofi, Ipsen, Novartis, Bayer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Diagnostics and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate Cancer Diagnostics and Treatment Market growing?

Ans: The Prostate Cancer Diagnostics and Treatment Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Prostate Cancer Diagnostics and Treatment Market size in 2031?

Ans: The Prostate Cancer Diagnostics and Treatment Market size in 2031 will be US$ 18900 million.

Who are the main players in the Prostate Cancer Diagnostics and Treatment Market report?

Ans: The main players in the Prostate Cancer Diagnostics and Treatment Market are Tolmar, Astellas Pharma, AstraZeneca, Ferring Pharmaceuticals, Johnson & Johnson, Abbott, Sanofi, Ipsen, Novartis, Bayer

What are the Application segmentation covered in the Prostate Cancer Diagnostics and Treatment Market report?

Ans: The Applications covered in the Prostate Cancer Diagnostics and Treatment Market report are Hospital, Research Institution, Clinic

What are the Type segmentation covered in the Prostate Cancer Diagnostics and Treatment Market report?

Ans: The Types covered in the Prostate Cancer Diagnostics and Treatment Market report are Biological Therapy, Chemotherapy

Recommended Reports

Cancer Diagnostics

Cancer Therapeutics

Cancer AI & Technology

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Diagnostics and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Biological Therapy

1.2.3 Chemotherapy

1.3 Market by Application

1.3.1 Global Prostate Cancer Diagnostics and Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Research Institution

1.3.4 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Diagnostics and Treatment Market Perspective (2020-2031)

2.2 Global Prostate Cancer Diagnostics and Treatment Growth Trends by Region

2.2.1 Global Prostate Cancer Diagnostics and Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Prostate Cancer Diagnostics and Treatment Historic Market Size by Region (2020-2025)

2.2.3 Prostate Cancer Diagnostics and Treatment Forecasted Market Size by Region (2026-2031)

2.3 Prostate Cancer Diagnostics and Treatment Market Dynamics

2.3.1 Prostate Cancer Diagnostics and Treatment Industry Trends

2.3.2 Prostate Cancer Diagnostics and Treatment Market Drivers

2.3.3 Prostate Cancer Diagnostics and Treatment Market Challenges

2.3.4 Prostate Cancer Diagnostics and Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate Cancer Diagnostics and Treatment Players by Revenue

3.1.1 Global Top Prostate Cancer Diagnostics and Treatment Players by Revenue (2020-2025)

3.1.2 Global Prostate Cancer Diagnostics and Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Prostate Cancer Diagnostics and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Prostate Cancer Diagnostics and Treatment Revenue

3.4 Global Prostate Cancer Diagnostics and Treatment Market Concentration Ratio

3.4.1 Global Prostate Cancer Diagnostics and Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics and Treatment Revenue in 2024

3.5 Global Key Players of Prostate Cancer Diagnostics and Treatment Head office and Area Served

3.6 Global Key Players of Prostate Cancer Diagnostics and Treatment, Product and Application

3.7 Global Key Players of Prostate Cancer Diagnostics and Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics and Treatment Breakdown Data by Type

4.1 Global Prostate Cancer Diagnostics and Treatment Historic Market Size by Type (2020-2025)

4.2 Global Prostate Cancer Diagnostics and Treatment Forecasted Market Size by Type (2026-2031)

5 Prostate Cancer Diagnostics and Treatment Breakdown Data by Application

5.1 Global Prostate Cancer Diagnostics and Treatment Historic Market Size by Application (2020-2025)

5.2 Global Prostate Cancer Diagnostics and Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Prostate Cancer Diagnostics and Treatment Market Size (2020-2031)

6.2 North America Prostate Cancer Diagnostics and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025)

6.4 North America Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate Cancer Diagnostics and Treatment Market Size (2020-2031)

7.2 Europe Prostate Cancer Diagnostics and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025)

7.4 Europe Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Size (2020-2031)

8.2 Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate Cancer Diagnostics and Treatment Market Size (2020-2031)

9.2 Latin America Prostate Cancer Diagnostics and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025)

9.4 Latin America Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Size (2020-2031)

10.2 Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Tolmar

11.1.1 Tolmar Company Details

11.1.2 Tolmar Business Overview

11.1.3 Tolmar Prostate Cancer Diagnostics and Treatment Introduction

11.1.4 Tolmar Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.1.5 Tolmar Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Details

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma Prostate Cancer Diagnostics and Treatment Introduction

11.2.4 Astellas Pharma Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.2.5 Astellas Pharma Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Prostate Cancer Diagnostics and Treatment Introduction

11.3.4 AstraZeneca Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.3.5 AstraZeneca Recent Development

11.4 Ferring Pharmaceuticals

11.4.1 Ferring Pharmaceuticals Company Details

11.4.2 Ferring Pharmaceuticals Business Overview

11.4.3 Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Introduction

11.4.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.4.5 Ferring Pharmaceuticals Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Prostate Cancer Diagnostics and Treatment Introduction

11.5.4 Johnson & Johnson Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Abbott Business Overview

11.6.3 Abbott Prostate Cancer Diagnostics and Treatment Introduction

11.6.4 Abbott Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.6.5 Abbott Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Prostate Cancer Diagnostics and Treatment Introduction

11.7.4 Sanofi Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 Ipsen

11.8.1 Ipsen Company Details

11.8.2 Ipsen Business Overview

11.8.3 Ipsen Prostate Cancer Diagnostics and Treatment Introduction

11.8.4 Ipsen Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.8.5 Ipsen Recent Development

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Prostate Cancer Diagnostics and Treatment Introduction

11.9.4 Novartis Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.9.5 Novartis Recent Development

11.10 Bayer

11.10.1 Bayer Company Details

11.10.2 Bayer Business Overview

11.10.3 Bayer Prostate Cancer Diagnostics and Treatment Introduction

11.10.4 Bayer Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

11.10.5 Bayer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Tolmar

Astellas Pharma

Astrazeneca plc

Ferring Pharmaceuticals

Johnson & Johnson

Abbott

Sanofi

Ipsen S A

Novartis

Bayer

List of Tables

Table 1. Global Prostate Cancer Diagnostics and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Biological Therapy

Table 3. Key Players of Chemotherapy

Table 4. Global Prostate Cancer Diagnostics and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Prostate Cancer Diagnostics and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Prostate Cancer Diagnostics and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Prostate Cancer Diagnostics and Treatment Market Share by Region (2020-2025)

Table 8. Global Prostate Cancer Diagnostics and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Prostate Cancer Diagnostics and Treatment Market Share by Region (2026-2031)

Table 10. Prostate Cancer Diagnostics and Treatment Market Trends

Table 11. Prostate Cancer Diagnostics and Treatment Market Drivers

Table 12. Prostate Cancer Diagnostics and Treatment Market Challenges

Table 13. Prostate Cancer Diagnostics and Treatment Market Restraints

Table 14. Global Prostate Cancer Diagnostics and Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Prostate Cancer Diagnostics and Treatment Market Share by Players (2020-2025)

Table 16. Global Top Prostate Cancer Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Treatment as of 2024)

Table 17. Ranking of Global Top Prostate Cancer Diagnostics and Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics and Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Prostate Cancer Diagnostics and Treatment, Headquarters and Area Served

Table 20. Global Key Players of Prostate Cancer Diagnostics and Treatment, Product and Application

Table 21. Global Key Players of Prostate Cancer Diagnostics and Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Prostate Cancer Diagnostics and Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Prostate Cancer Diagnostics and Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Prostate Cancer Diagnostics and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Prostate Cancer Diagnostics and Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Prostate Cancer Diagnostics and Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Prostate Cancer Diagnostics and Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Prostate Cancer Diagnostics and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Prostate Cancer Diagnostics and Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Prostate Cancer Diagnostics and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Prostate Cancer Diagnostics and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Prostate Cancer Diagnostics and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Tolmar Company Details

Table 47. Tolmar Business Overview

Table 48. Tolmar Prostate Cancer Diagnostics and Treatment Product

Table 49. Tolmar Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 50. Tolmar Recent Development

Table 51. Astellas Pharma Company Details

Table 52. Astellas Pharma Business Overview

Table 53. Astellas Pharma Prostate Cancer Diagnostics and Treatment Product

Table 54. Astellas Pharma Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 55. Astellas Pharma Recent Development

Table 56. AstraZeneca Company Details

Table 57. AstraZeneca Business Overview

Table 58. AstraZeneca Prostate Cancer Diagnostics and Treatment Product

Table 59. AstraZeneca Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 60. AstraZeneca Recent Development

Table 61. Ferring Pharmaceuticals Company Details

Table 62. Ferring Pharmaceuticals Business Overview

Table 63. Ferring Pharmaceuticals Prostate Cancer Diagnostics and Treatment Product

Table 64. Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 65. Ferring Pharmaceuticals Recent Development

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Prostate Cancer Diagnostics and Treatment Product

Table 69. Johnson & Johnson Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. Abbott Company Details

Table 72. Abbott Business Overview

Table 73. Abbott Prostate Cancer Diagnostics and Treatment Product

Table 74. Abbott Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 75. Abbott Recent Development

Table 76. Sanofi Company Details

Table 77. Sanofi Business Overview

Table 78. Sanofi Prostate Cancer Diagnostics and Treatment Product

Table 79. Sanofi Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 80. Sanofi Recent Development

Table 81. Ipsen Company Details

Table 82. Ipsen Business Overview

Table 83. Ipsen Prostate Cancer Diagnostics and Treatment Product

Table 84. Ipsen Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 85. Ipsen Recent Development

Table 86. Novartis Company Details

Table 87. Novartis Business Overview

Table 88. Novartis Prostate Cancer Diagnostics and Treatment Product

Table 89. Novartis Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 90. Novartis Recent Development

Table 91. Bayer Company Details

Table 92. Bayer Business Overview

Table 93. Bayer Prostate Cancer Diagnostics and Treatment Product

Table 94. Bayer Revenue in Prostate Cancer Diagnostics and Treatment Business (2020-2025) & (US$ Million)

Table 95. Bayer Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Prostate Cancer Diagnostics and Treatment Picture

Figure 2. Global Prostate Cancer Diagnostics and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Prostate Cancer Diagnostics and Treatment Market Share by Type: 2024 VS 2031

Figure 4. Biological Therapy Features

Figure 5. Chemotherapy Features

Figure 6. Global Prostate Cancer Diagnostics and Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Prostate Cancer Diagnostics and Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Research Institution Case Studies

Figure 10. Clinic Case Studies

Figure 11. Prostate Cancer Diagnostics and Treatment Report Years Considered

Figure 12. Global Prostate Cancer Diagnostics and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Prostate Cancer Diagnostics and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Prostate Cancer Diagnostics and Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Prostate Cancer Diagnostics and Treatment Market Share by Players in 2024

Figure 16. Global Top Prostate Cancer Diagnostics and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics and Treatment Revenue in 2024

Figure 18. North America Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Prostate Cancer Diagnostics and Treatment Market Share by Country (2020-2031)

Figure 20. United States Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Prostate Cancer Diagnostics and Treatment Market Share by Country (2020-2031)

Figure 24. Germany Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Prostate Cancer Diagnostics and Treatment Market Share by Region (2020-2031)

Figure 32. China Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Prostate Cancer Diagnostics and Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Prostate Cancer Diagnostics and Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Prostate Cancer Diagnostics and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Tolmar Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 48. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 49. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 50. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 51. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 52. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 54. Ipsen Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 56. Bayer Revenue Growth Rate in Prostate Cancer Diagnostics and Treatment Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prostate Cancer Market Insights Forecast to 2030

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Castration Resistant Prostate Cancer Treatment Market Research Report 2024

Global Tumor Marker Testing Market Research Report 2024

Global Prostate Cancer Devices Market Research Report 2025

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Prostate Cancer Minimally Invasive Surgery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cancer Pain Market Insights Forecast to 2030

Global Metastatic Prostate Cancer Treatment Market Research Report 2024

Minimally Invasive Prostate Cancer Surgery Market

Global Precision Cancer Tests Market Research Report 2024

Global Prostate Cancer Nuclear Medicine Diagnostics Market Insights Forecast to 2030

Precision Cancer Diagnostic Tests Market

Prostate Biopsy Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Treatment Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030

Global At Home Prostate Cancer Testing Market Research Report 2024

Global Male Breast Cancer Treatment Market Insights Forecast to 2030

Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions